Xenetic Biosciences is a biopharmaceutical company that provides drugs, cancer therapies, and vaccines.
Xenetic Biosciences has raised $4.5M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in October 2025.
Xenetic Biosciences's investors include Baxter International.
Xenetic Biosciences is headquartered in Framingham, United States.
Xenetic Biosciences is a biopharmaceutical company that provides drugs, cancer therapies, and vaccines.
Xenetic Biosciences is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Xenetic Biosciences — Funding & Investors." VCBacked, October 10, 2025, https://www.vcbacked.co/company/xenetic-biosciences. Accessed August 14, 2026.
VCBacked. (2025). Xenetic Biosciences — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/xenetic-biosciences
{{cite web |title=Xenetic Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/xenetic-biosciences |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated